top of page

Phage Competition

As antibiotic resistance grows more frequent for common bacterial infections, alternative treatment strategies such as phage therapy have become more widely studied in the medical field. While many studies have explored the efficacy of antibiotics, phage therapy, or synergistic combinations of phages and antibiotics, the impact of virus competition on the efficacy of antibiotic treatment has not yet been considered. Here, we model the synergy between antibiotics and two viral types, temperate and chronic, in controlling bacterial infections. We demonstrate that while combinations of antibiotic and temperate viruses exhibit synergy, competition between temperate and chronic viruses inhibits bacterial control with antibiotics. In fact, our model reveals that antibiotic treatment may counterintuitively increase the bacterial load when a large fraction of the bacteria develop antibiotic-resistance.

bacteriophage-IDH-colours.jpg

A bacteriophage that infects Pseudomonas aeruginosa

index.jpg

Pseudomonas aeruginosa

In collaboration with Zoi Rapti, Rachel Whitaker, Ted Kim, Jaya Chandrashekhar, George O'Toole, and undergraduate researchers Kylie Landa and Lauren Mossman

 

Clifton SM, Kim T, Chandrashekhar JH, O'Toole GA, Rapti Z, Whitaker RJ (2019)

Lying in wait: Modeling the control of bacterial infections via antibiotic-induced proviruses.

mSystems 4, 5

DOI:10.1128/mSystems.00221-19

​

Preprint

​

Clifton SM, Whitaker RJ, Rapti Z (2021)

Temperate and chronic virus competition leads to low latency fractions.

Journal of Theoretical Biology 523, 110710

DOI:10.1016/j.jtbi.2021.110710

​

Preprint

​

Landa KJ, Mossman LM, Whitaker RJ, Rapti Z, Clifton SM (2022)

Phage-antibiotic synergy inhibited by temperate and chronic virus competition.

Bulletin of Mathematical Biology 84, 54

DOI:10.1007/s11538-022-01006-6

​

Preprint

bottom of page